What the Precision Diabetes and Nagase Diagnostics deal means for glycated albumin testing
Precision Diabetes and Nagase Diagnostics target wider U.S. access for Lucica, an FDA-cleared assay for two-to-three-week glycemic monitoring.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
How AnX Robotica’s NaviCONNECT platform could change capsule endoscopy practice management
AnX Robotica launches NaviCONNECT to bring NaviCam capsule studies, AI-assisted review and multi-site workflows into a secure cloud platform.
Medical Devices & Diagnostics
Brandage targets children’s first-aid market with tattoo-transfer bandage design
Brandage takes tattoo-transfer adhesive bandages to ASD Market Week, testing whether playful wound care can win national retail distribution.
Medical Devices & Diagnostics
How Beckman Coulter DxU 1800 combines urine chemistry and digital microscopy
Beckman Coulter launches DxU 1800 to automate urine chemistry and microscopy as laboratories face higher testing volumes and staffing pressure.
Medical Devices & Diagnostics
ALZpath just gave Alamar a bigger Alzheimer’s diagnostics role, but the regulatory test starts now
ALZpath expands its Alamar Biosciences deal into clinical diagnostics, opening a new path for pTau217 blood tests in Alzheimer’s disease.
Medical Devices & Diagnostics
HOPPR’s chest CT model tackles radiology’s hardest AI test, but validation will decide what comes next
HOPPR adds a chest CT narrative model, widening developer access while leaving validation, regulation and workflow adoption as the key tests.
Medical Devices & Diagnostics
MolecuLight study tests fluorescence-guided debridement in infected knee revision surgery
MolecuLightDX detected residual fluorescent bacterial signals after knee debridement, but larger trials must prove better infection outcomes.
Medical Devices & Diagnostics
Momentis Surgical Anovo FDA clearance expands robotic surgery to multiport procedures
Momentis Surgical wins FDA clearance for Anovo multiport surgery, widening its robotic platform while adoption and evidence remain key.
Medical Devices & Diagnostics
How the Teal Health UC Davis pilot could reshape cervical cancer screening workflows
Teal Health and UC Davis Health test how FDA-authorized at-home HPV screening can fit routine care and reach overdue patients.
Medical Devices & Diagnostics
Fapon’s ADLM 2026 showcase looks bigger than a product launch. Here is the real diagnostics strategy
Fapon unveils AI-engineered PCR enzymes and Alzheimer’s biomarker reagents at ADLM 2026, targeting faster North American IVD development.